Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Recurrent B-Cell Non-Hodgkin Lymphoma
- Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
- Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- BIOLOGICAL: Epcoritamab
- DRUG: Lenalidomide
- PROCEDURE: Magnetic Resonance Imaging
- PROCEDURE: Positron Emission Tomography
Sponsor
Northwestern University
Collaborators